300683 Wuhan Hiteck Biological Pharma
- 30.35
- -1.55-4.86%
Wuhan Hiteck Biological Pharma News
Haite Biotech: Prompt announcement for disclosure of the report for the third quarter of 2024
Haite Biotech: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Haite Biotech: Summary table on the use of non-operating funds and other related capital transactions for the first half year of 2024
Haite Biotech: Announcement on the extension of some fund-raising investment projects
Haite Biotech: Prompt Announcement on 2024 Semi-Annual Report and Summary Disclosure
Wuhan Hiteck Biological Pharma: Progress Announcement on the Use of Surplus Self-Owned Funds to Purchase Wealth Management Products
Wuhan Hiteck Biological Pharma: Announcement on the Progress of Using Idle Proprietary Funds and Raised Funds to Purchase Financial Products.
Wuhan Hiteck Biological Pharma: Announcement Regarding the Plan of Introducing External Investors for Capital Increase in Wholly-owned Subsidiary.
Wuhan Hiteck Biological Pharma: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Wuhan Hiteck Biological Pharma: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the Company's 2023 Annual General Meeting of Shareholders
Wuhan Hiteck Biological Pharma: Announcement on the progress of foreign investment
Haite Biotech: Announcement on amending the company's articles of association
Haite Biotech: Notice on Revising and Formulating Systems Related to Corporate Governance
Haite Biotech: 2023 Annual Financial Report
Haite Biotech: 2023 Financial Report
Haite Biotech: Notice on convening the 2023 Annual General Meeting of Shareholders
Haite Biotech: Internal Control Self-Assessment Report
Haite Biotech: Prompt Announcement for Disclosure of the 2023 Annual Report
Haite Biotech: Working System for Special Meetings of Independent Directors
Haite Biotech: Prompt Announcement on Report Disclosure for the First Quarter of 2024
Analysis
Price Target
No Data
No Data